New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia
Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Adagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5th
Adagio Medical (NASDAQ:ADGM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness